经口机器人手术治疗口咽涎腺恶性肿瘤的全国性分析
基于美国国家癌症数据库2010-2017年785例T1-T4a无远处转移的口咽涎腺恶性肿瘤手术患者,比较经口机器人手术(TORS)与非机器人手术的围手术期结局和总生存。
要点
- 两组切缘阳性率、30天死亡率和总生存无显著差异。
核心结论
- TORS可能是经过适当选择的口咽涎腺恶性肿瘤患者的可行治疗方式。
研究设计与样本
- 回顾性分析美国国家癌症数据库(NCDB)2010-2017年数据,纳入785例T1-T4a无远处转移的口咽涎腺恶性肿瘤手术患者,按手术方式分为TORS组与非机器人组。
主要发现
- 两组切缘阳性率、30天死亡率和总生存无显著差异。
- 非软腭原发部位(OR=12.9,95%CI 6.6-25.2)和学术机构治疗(OR=2.0,95%CI 1.2-3.5)与采用TORS独立相关。
临床怎么用
- 对于经适当选择的口咽涎腺恶性肿瘤患者,TORS可作为可行的手术选择。
- 采用TORS时需关注30天非计划再入院风险。
- 舌根肿瘤患者采用TORS可能缩短住院时间。
局限性
- 本研究为基于NCDB的回顾性分析,存在数据库固有局限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: (1) To compare perioperative outcomes and overall survival of patients with oropharyngeal salivary gland malignancies (OPSGMs) treated with transoral robotic surgery (TORS) versus other approaches. (2) To identify clinical factors associated with a robotic surgical approach. STUDY DESIGN: Retrospective analysis of the National Cancer Database (NCDB). SETTING: NCDB. METHODS: Data obtained from the NCDB were analyzed between 2010 and 2017 for patients with T1-T4a OPSGMs without distant metastases treated surgically. Patients were stratified by surgical approach (TORS vs nonrobotic), and clinicopathologic factors were compared with the t test or chi-square test for continuous or categorical variables, respectively. Overall survival was analyzed by patient demographics and clinical factors according to Kaplan-Meier and Cox proportional hazards models. Factors associated with TORS were assessed with logistic regression. RESULTS: A total of 785 patients were analyzed. A non-soft palate primary site (odds ratio, 12.9; 95% CI, 6.6-25.2) and treatment at an academic facility (odds ratio, 2.0; 95% CI, 1.2-3.5) were independently associated with TORS. There were no significant differences in the positive margin rate, 30-day mortality, or overall survival between the groups. The 30-day unplanned readmission rate was higher in patients treated with TORS versus nonrobotic resections (5.8% vs 1.7%, P = .0004). When stratified by tumor subsite, there was a significant decrease in hospital length of stay in patients with tongue base tumors undergoing TORS versus nonrobotic resections (P = .029). CONCLUSION: This study suggests that TORS may be a viable treatment modality for appropriately selected patients with OPSGM.
引用
- Bollig CA, Wang K, Llerena P, et al. National Analysis of Oropharyngeal Salivary Gland Malignancies Treated With Transoral Robotic Surgery. Otolaryngol Head Neck Surg. 2021. PMID: 34311621. doi:10.1177/01945998211031161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。